4.0 Article

Waiting list mortality and the potential of donation after circulatory death heart transplantations in the Netherlands

Journal

NETHERLANDS HEART JOURNAL
Volume 29, Issue 2, Pages 88-97

Publisher

BOHN STAFLEU VAN LOGHUM BV
DOI: 10.1007/s12471-020-01505-y

Keywords

Donation after circulatory death; Heart transplantation; Waiting list; Mortality

Ask authors/readers for more resources

There is a high waiting list mortality rate in the Netherlands for heart transplantation, while utilizing organs from DCD donors shows great potential and could potentially reduce waiting list mortality. Cardiac screening will be necessary to determine the true potential of this approach.
Background With more patients qualifying for heart transplantation (HT) and fewer hearts being transplanted, it is vital to look for other options. To date, only organs from brain-dead donors have been used for HT in the Netherlands. We investigated waiting list mortality in all Dutch HT centres and the potential of donation after circulatory death (DCD) HT in the Netherlands. Methods Two different cohorts were evaluated. One cohort was defined as patients who were newly listed or were already on the waiting list for HT between January 2013 and December 2017. Follow-up continued until September 2018 and waiting list mortality was calculated. A second cohort of all DCD donors in the Netherlands (lung, liver, kidney and pancreas) between January 2013 and December 2017 was used to calculate the potential of DCD HT. Results Out of 395 patients on the waiting list for HT, 196 (50%) received transplants after a median waiting time of 2.6 years. In total, 15% died while on the waiting list before a suitable donor heart became available. We identified 1006 DCD donors. After applying exclusion criteria and an age limit of 50 years, 122 potential heart donors remained. This number increased to 220 when the age limit was extended to 57 years. Conclusion Waiting list mortality in the Netherlands is high. HT using organs from DCD donors has great potential in the Netherlands and could lead to a reduction in waiting list mortality. Cardiac screening will eventually determine the true potential.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available